BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22993404)

  • 1. Rat Mcs1b is concordant to the genome-wide association-identified breast cancer risk locus at human 5q11.2 and MIER3 is a candidate cancer susceptibility gene.
    denDekker AD; Xu X; Vaughn MD; Puckett AH; Gardner LL; Lambring CJ; Deschenes L; Samuelson DJ
    Cancer Res; 2012 Nov; 72(22):6002-12. PubMed ID: 22993404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenic rats reveal three independent Copenhagen alleles within the Mcs1 quantitative trait locus that confer resistance to mammary cancer.
    Haag JD; Shepel LA; Kolman BD; Monson DM; Benton ME; Watts KT; Waller JL; Lopez-Guajardo CC; Samuelson DJ; Gould MN
    Cancer Res; 2003 Sep; 63(18):5808-12. PubMed ID: 14522903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Confirmation and Comparative Genomics of the Rat
    Le S; Martin ZC; Samuelson DJ
    G3 (Bethesda); 2017 Jun; 7(6):1767-1773. PubMed ID: 28391240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat Mammary carcinoma susceptibility 3 (Mcs3) pleiotropy, socioenvironmental interaction, and comparative genomics with orthologous human 15q25.1-25.2.
    Duderstadt EL; Samuelson DJ
    G3 (Bethesda); 2023 Jan; 13(1):. PubMed ID: 36315068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6.
    Sanders J; Haag JD; Samuelson DJ
    PLoS One; 2011; 6(5):e19891. PubMed ID: 21625632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical evidence of Mcs5, a QTL controlling mammary carcinoma susceptibility, in congenic rats.
    Samuelson DJ; Haag JD; Lan H; Monson DM; Shultz MA; Kolman BD; Gould MN
    Carcinogenesis; 2003 Sep; 24(9):1455-60. PubMed ID: 12844486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine mapping reveals multiple loci and a possible epistatic interaction within the mammary carcinoma susceptibility quantitative trait locus, Mcs5.
    Samuelson DJ; Aperavich BA; Haag JD; Gould MN
    Cancer Res; 2005 Nov; 65(21):9637-42. PubMed ID: 16266982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance.
    Cotroneo MS; Merry GM; Haag JD; Lan H; Shepel LA; Gould MN
    Oncogene; 2006 Aug; 25(36):5011-7. PubMed ID: 16568087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant overlap between human genome-wide association-study nominated breast cancer risk alleles and rat mammary cancer susceptibility loci.
    Sanders J; Samuelson DJ
    Breast Cancer Res; 2014 Jan; 16(1):R14. PubMed ID: 24467842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions.
    Smits BM; Sharma D; Samuelson DJ; Woditschka S; Mau B; Haag JD; Gould MN
    Breast Cancer Res; 2011 Aug; 13(4):R81. PubMed ID: 21846333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.
    Smits BM; Haag JD; Rissman AI; Sharma D; Tran A; Schoenborn AA; Baird RC; Peiffer DS; Leinweber DQ; Muelbl MJ; Meilahn AL; Eichelberg MR; Leng N; Kendziorski C; John MC; Powers PA; Alexander CM; Gould MN
    PLoS Genet; 2013 Jun; 9(6):e1003549. PubMed ID: 23785296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mcs5c: a mammary carcinoma susceptibility locus located in a gene desert that associates with tenascin C expression.
    Veillet AL; Haag JD; Remfert JL; Meilahn AL; Samuelson DJ; Gould MN
    Cancer Prev Res (Phila); 2011 Jan; 4(1):97-106. PubMed ID: 21205740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
    Glubb DM; Maranian MJ; Michailidou K; Pooley KA; Meyer KB; Kar S; Carlebur S; O'Reilly M; Betts JA; Hillman KM; Kaufmann S; Beesley J; Canisius S; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Schmidt MK; Broeks A; Hogervorst FB; van der Schoot CE; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Ruebner M; Ekici AB; Beckmann MW; Peto J; dos-Santos-Silva I; Fletcher O; Johnson N; Pharoah PD; Bolla MK; Wang Q; Dennis J; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Burwinkel B; Marme F; Yang R; Surowy H; Guénel P; Truong T; Menegaux F; Sanchez M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; González-Neira A; Benitez J; Zamora MP; Arias Perez JI; Anton-Culver H; Neuhausen SL; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Brauch H; Ko YD; Brüning T; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Tanaka H; Dörk T; Bogdanova NV; Helbig S; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Zhao H; Weltens C; van Limbergen E; Chang-Claude J; Flesch-Janys D; Rudolph A; Seibold P; Radice P; Peterlongo P; Barile M; Capra F; Couch FJ; Olson JE; Hallberg E; Vachon C; Giles GG; Milne RL; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; See MH; Cornes B; Cheng CY; Ikram MK; Kristensen V; ; Zheng W; Halverson SL; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Darabi H; Eriksson M; Hooning MJ; Hollestelle A; Martens JW; Collée JM; Hall P; Li J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Cross SS; Reed MW; Blot W; Signorello LB; Cai Q; Shah M; Ghoussaini M; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Miao H; Lim WY; Tang A; Hamann U; Torres D; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Olswold C; Slager S; Toland AE; Yannoukakos D; Shen CY; Wu PE; Yu JC; Hou MF; Swerdlow A; Ashworth A; Orr N; Jones M; Pita G; Alonso MR; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Healey CS; Brown MA; Ponder BA; Chenevix-Trench G; Thompson DJ; Edwards SL; Easton DF; Dunning AM; French JD
    Am J Hum Genet; 2015 Jan; 96(1):5-20. PubMed ID: 25529635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humans.
    Colletti JA; Leland-Wavrin KM; Kurz SG; Hickman MP; Seiler NL; Samanas NB; Eckert QA; Dennison KL; Ding L; Schaffer BS; Shull JD
    G3 (Bethesda); 2014 May; 4(8):1385-94. PubMed ID: 24875630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.
    Schaffer BS; Leland-Wavrin KM; Kurz SG; Colletti JA; Seiler NL; Warren CL; Shull JD
    Cancer Prev Res (Phila); 2013 Jan; 6(1):59-69. PubMed ID: 23151807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk.
    Samuelson DJ; Hesselson SE; Aperavich BA; Zan Y; Haag JD; Trentham-Dietz A; Hampton JM; Mau B; Chen KS; Baynes C; Khaw KT; Luben R; Perkins B; Shah M; Pharoah PD; Dunning AM; Easton DF; Ponder BA; Gould MN
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6299-304. PubMed ID: 17404222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene.
    Hsu LC; Kennan WS; Shepel LA; Jacob HJ; Szpirer C; Szpirer J; Lander ES; Gould MN
    Cancer Res; 1994 May; 54(10):2765-70. PubMed ID: 8168109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential 12-O-Tetradecanoylphorbol-13-acetate-induced activation of rat mammary carcinoma susceptibility Fbxo10 variant promoters via a PKC-AP1 pathway.
    Xu X; Prough RA; Samuelson DJ
    Mol Carcinog; 2015 Feb; 54(2):134-47. PubMed ID: 24008983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically determined inflammatory-response related cytokine and chemokine transcript profiles between mammary carcinoma resistant and susceptible rat strains.
    Devapatla B; Sanders J; Samuelson DJ
    Cytokine; 2012 Aug; 59(2):223-7. PubMed ID: 22609213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic identification of multiple loci that control breast cancer susceptibility in the rat.
    Shepel LA; Lan H; Haag JD; Brasic GM; Gheen ME; Simon JS; Hoff P; Newton MA; Gould MN
    Genetics; 1998 May; 149(1):289-99. PubMed ID: 9584103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.